CAS: 34482-99-0; 7-Chloro-5-(2-Fluorophenyl)-1-(2,2,2-Trifluoroethyl)-2,3-Dihydro-1,4-Benzodiazepine

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      📜2-[(β,β,β-Trifluoroethyl)-(β-Bromoethyl)]Amino-5-Chloro-2'-Fluorobenzophenone置于溴化铵,乌洛托品体系中,化学反应生成氟乙西泮
      参考文献:Process For The Preparation Of 1,4-Benzo-Diazepines And
      标题:Process For The Preparation Of 1,4-Benzo-Diazepines And
      摘要:这项发明涉及一种改进的制备1,3-二氢-2H-1,4-苯并二氮杂环己酮和2,3-二氢-1H-1,4-苯并二氮杂环烷的方法,通过在存在己亚胺,含有5至50体积百分比水的可溶于水的醇和铵盐的情况下,将2-(2-卤代酰胺基)-苯并酮或2-(2-卤代乙基氨基)-苯并酮进行缩合反应.

      海关参考信息

      专利信息


      专利号:US-2022233673-A1
      优先权日:2019-06-04
      标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
      发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
      权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
      摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

      专利号:US-2014315720-A1
      优先权日:2012-10-24
      标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
      发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
      权利人:CELANESE ACETATE LLC
      摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知